Sign in Pull a receipt

LEXX

Lexaria Bioscience Corp.

Healthcare · Biotechnology

$377.80 sample

-1.15 (-0.30%) 1D

Market cap

$2.14T

Price as of

2026-10-29

Latest filing

8-K · 2026-10-22

Alerts

8

Price$377.80 +30.78% 3M daily closessample

378.95288.89

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 27INSInsider sell: Chief Financial Officer
Oct 22SEC8-K filed: material event
Oct 15INSInsider buy: Chief Executive Officer
Oct 12INSInsider sell: General Counsel
Oct 07INSInsider buy: 10% owner
Sep 30INSInsider sell: EVP, Operations
Sep 24SECForm 144 filed
Sep 18INSInsider sell: 10% owner

Sign up to see the real LEXX record →

Company facts

SEC EDGAR registration

Name: Lexaria Bioscience Corp.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -9sample, -100 to +100
Reporting currency: USD

Who is positioning in LEXX

sample

Insiders: 24 insider transactions over 90 days, net selling, $722.1M
Congress: 5 members traded over 90 days
Institutions · 13F: 31 funds hold $38.7B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$124.5B +17.5% y/y

Q4 2024Q3 2026

Inventory$74.5B +13.3% y/y

Q4 2024Q3 2026

Accounts receivable$56.0B +11.1% y/y

Q4 2024Q3 2026

Total debt$141.3B +11.5% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $1.71T +4.6% 3M
Sample peer B: $2.11T -3.6% 3M
Sample peer C: $1.48T +11.6% 3M
Sample peer D: $2.13T -5.5% 3M
Sample peer E: $552.6B -6.0% 3M